祁連山(600720.SH):一季度淨利預減87%-99%
格隆匯4月7日丨祁連山(600720.SH)公佈2022年一季度業績預減公吿,公司2022年一季度實現歸屬於上市公司股東的淨利潤與上年同期相比預計減少4100萬元到4600萬元,同比減少87%到99%。
公司2022年一季度實現歸屬於上市公司股東的扣除非經常性損益的淨利潤與上年同期相比預計減少2800萬元到3300萬元,同比減少73%到88%。
業績預減的主要原因:一是受原煤採購價格上漲影響,產品銷售成本同比上升,致使產品毛利有所下降;二是公司所在部分區域受新冠疫情影響,導致水泥銷量同比減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.